Results 11 to 20 of about 6,409,949 (276)

Hypermobile Ehlers-Danlos Syndrome: A Prodromal Subtype of Functional Movement Disorders? [PDF]

open access: yesMov Disord Clin Pract, 2022
The phenotypic diversity of functional movement disorders (FMD) is considered a reflection of its many etiological subtypes. Ehlers‐Danlos syndrome (EDS), a joint hypermobility syndrome, also has variable phenotypes, which may include functional symptoms.
Margolesky J, Puentes D, Espay AJ.
europepmc   +3 more sources

Neuroimaging in Functional Movement Disorders [PDF]

open access: yesCurrent Neurology and Neuroscience Reports, 2019
Purpose of ReviewFunctional movement disorders are common and disabling causes of abnormal movement control. Here, we review the current state of the evidence on the use of neuroimaging in Functional movement disorders, particularly its role in helping ...
Mark J. Edwards, Tiago Teodoro
exaly   +3 more sources

Use of non-invasive neurostimulation for rehabilitation in functional movement disorders. [PDF]

open access: yesFront Rehabil Sci, 2022
Functional movement disorders (FMD) are a subtype of functional neurological disorders which involve abnormal movements and include multiple phenomenologies. There is a growing interest in the mechanism, diagnosis, and treatment of these disorders.
Grippe T, Desai N, Arora T, Chen R.
europepmc   +2 more sources

Theory of mind: A clue for the interpretation of functional movement disorders. [PDF]

open access: yesActa Neurol Scand, 2022
Functional movement disorders (FMD) refer to a heterogeneous group of manifestations incongruent with known neurological diseases. Functional neuroimaging studies in FMD indicate the overlap between cerebral regions in which abnormal activation occurs ...
Silveri MC   +9 more
europepmc   +2 more sources

Functional Movement Disorders: Updates and Clinical Overview. [PDF]

open access: yesJ Mov Disord
Functional movement disorder (FMD) is a type of functional neurological disorder that is common but often difficult to diagnose or manage. FMD can present as various phenotypes, including tremor, dystonia, myoclonus, gait disorders, and parkinsonism ...
Park JE.
europepmc   +2 more sources

Increased beta synchronization underlies perception-action hyperbinding in functional movement disorders. [PDF]

open access: yesBrain Commun
Functional movement disorders are amongst the most common and disabling neurological conditions, placing a significant burden on the healthcare system.
Pastötter B   +12 more
europepmc   +2 more sources

Gender disparity and abuse in functional movement disorders: a multi-center case-control study. [PDF]

open access: yesJ Neurol, 2022
To determine gender differences in rates of sexual and physical abuse in functional movement disorders compared to controls and evaluate if the gender disparity of functional movement disorders is associated with abuse history.
Kletenik I   +16 more
europepmc   +2 more sources

Functional tics: Expanding the phenotypes of functional movement disorders? [PDF]

open access: yesEuropean Journal of Neurology, 2023
Until the outbreak reported during the COVID‐19 pandemic, functional tics were considered to be a relatively rare clinical phenotype, as opposed to other functional movement disorders such as functional tremor and dystonia.
A. Cavanna   +4 more
semanticscholar   +2 more sources

Combined Physiotherapy and Cognitive Behavioral Therapy for Functional Movement Disorders: A Randomized Clinical Trial.

open access: yesJAMA Neurol
Importance Functional movement disorders (FMDs) are frequent and disabling neurological disorders with a substantial socioeconomic impact. Few randomized studies have analyzed the effectiveness of combined physiotherapy and psychotherapy in patients ...
Macías-García D   +13 more
europepmc   +2 more sources

Evaluation of Individualized Multi-Disciplinary Inpatient Treatment for Functional Movement Disorders. [PDF]

open access: yesMov Disord Clin Pract, 2021
Functional movement disorders (FMD) are associated with considerable morbidity and impairment of quality of life. Specialized treatment is scarce and data on efficacy of different therapies are limited.
Schmidt T   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy